Navigation Links
Study reveals risk factors for blood clots in pregnant and postnatal women
Date:4/2/2013

00 pregnancies.

Researchers identified all women who developed VTE for the first time during their pregnancy, including deep vein thrombosis (DVT), then extracted important key information about the mother from their medical records including their age, body mass index (BMI) and whether they smoked.

In addition, they considered other pregnancy-related factors such as how the baby was delivered, whether it was a stillbirth or premature birth and any associated complications including pre-eclampsia, diabetes and high blood pressure.

Co-existing medical factors including varicose veins, inflammatory bowel disease (IBD) and heart conditions such as heart disease were also taken into account.

They then used sophisticated data analysis methods to calculate the incident rate ratios to compare the risks of VTE to people without the specified risk factor.

They discovered that the risk of VTE during pregnancy was only marginally higher for women who were aged over 35 years old, had a BMI greater than 25 or who smoked. Medical complications such as pre-existing diabetes, varicose veins and IBD were all associated with greater risk, but not pre-existing high blood pressure.

The risks were much higher for new mothers. Postnatal women with a BMI greater than 30 were four times more likely to develop a VTE, while delivery by caesarean section, multiple previous births (three or more), bleeding in pregnancy and premature birth all doubled the chances of a women developing a VTE.

Perhaps most significantly, women who suffered a still birth were six times more likely to have a VTE.

Dr Grainge added: "Our results may have important implications for the way that preventative measures for VTE are delivered in healthcare settings in developed countries. We believe the strong association between stillbirths and premature births and VTE in particular is a finding of real importance which has received only limited atten
'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. Law that regulates shark fishery is too liberal: UBC study
3. New study will help protect vulnerable birds from impacts of climate change
4. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
5. BYU study: Using a gun in bear encounters doesnt make you safer
6. 15-year study: When it comes to creating wetlands, Mother Nature is in charge
7. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
8. Crystal structure of archael chromatin clarified in new study
9. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
10. University of Houston study shows BP oil spill hurt marshes, but recovery possible
11. Study demonstrates cells can acquire new functions through transcriptional regulatory network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, reminds investors and media that  Mr. David Tunnell ... SECURE CONNEXIONS AMERICA 2015, held in Washington DC ... conference is organized into a series of nine session tracks. ... Fraud: Where is the Trust in Cyberspace? and will ...
(Date:4/27/2015)... Apr. 27, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... pre-order customers the first week of May, 2015 and ... of May. Gino Pereira , ... for the company as Wocket® enters the consumer market. ...
(Date:4/21/2015)... , April 21, 2015 ... evolving government policies are boosting access control systems market ... According to a recently published report by TechSci ... 2020 ", the access control systems market in ... USD1.2 billion by 2020.The access control systems market in ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
... at riding a bike, tying a tie, or playing the ... explain or teach those skills to someone else. These ... whereas classroom instruction and information read in a book are ... Ashby, professor and chair of UC Santa Barbara,s Department of ...
... University] Living with HIV is difficult under the ... alcohol consumption can become particularly perilous in intricate ways ... Brown Alcohol Research Center on HIV (ARCH) funded by ... of Health, Brown University scientists will study the health ...
... the International Osteoporosis Foundation (IOF) for World Osteoporosis Day ... fractures and calls on health professionals to recognize the ... "The widespread underdiagnosis and lack of treatment of spinal ... chronic pain, deformity, disability and at high risk of ...
Cached Biology News:Frontal lobe of the brain is key to automatic responses to various stimuli, say scientists 2$7.5M grant to fund research on interaction of drinking and HIV infection 2$7.5M grant to fund research on interaction of drinking and HIV infection 3Devastating impact of spinal osteoporotic fractures revealed on World Osteoporosis Day 2
(Date:5/26/2015)... WORMS, GERMANY (PRWEB) May 26, 2015 ... W. R. Grace & Co. (NYSE: GRA) announces ... received good manufacturing practice (GMP) certification from EXCiPACTâ„¢, ... distributors of pharmaceutical excipients. , All ... brand of pharmaceutical grade excipient silica gels have ...
(Date:5/26/2015)... Md. , May 26, 2015   Intrexon Corporation ... announced today that Gregory Frost , Ph.D., Senior Vice ... the Jefferies 2015 Global Healthcare Conference on Wednesday, June 3 ... Hyatt in New York City . ... XON ) is Powering the Bioindustrial Revolution with Better DNA ...
(Date:5/26/2015)... , May 26, 2015   PDI , ... today announced that Oakwood Healthcare in ... the winning entry in Delivering the ... who display excellence in building collaborative relationships between ... in healthcare facilities.  Oakwood Healthcare,s ...
(Date:5/26/2015)... ANGELES , May 26, 2015 Mr. ... his family, thanks President Barack Obama and President ... during the time of loss of Dr. Rongxiang Xu ... humanitarian and a leader ahead of his time, Dr. Xu,s ... the community leave a legacy that will not be forgotten. ...
Breaking Biology Technology:CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Intrexon to Present at the Jefferies 2015 Global Healthcare Conference 2PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3Dr. Rongxiang Xu, Beyond A Legend 2
... (EST):, "CYT006-AngQb, a Vaccine Against Hypertension Targeting Angiotensin II, ... Pressure.", The American Heart Association Publishes Today an Independent News Release ... ... no, Vaccine-Related Adverse Events Reported in 12 Months Follow-Up Period., ...
... Solutions Diagnostics, ERLANGEN, Germany, Nov. 6 ... Dade Behring Holdings, Inc. The,laboratory diagnostics company ... Diagnostics. As the market leader in the ... diagnostics, Siemens now can offer its,customers a ...
... November 6 AIM-quoted drug discovery,company Verona Pharma ... the planned development of its anti-asthma and hay ... compound, RPL554, is now entering a,second 28-day experimental ... demonstrate safety, before moving onto the proof of ...
Cached Biology Technology:Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 2Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 3Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 4Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 5Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 6Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007 7Siemens Completes Acquisition of Dade Behring 2Siemens Completes Acquisition of Dade Behring 3AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies 2